Fairness in Medical Image Classification

Deep learning has advanced chest X-ray (CXR) diagnosis, yet demographic biases in learned representations may contribute to performance disparities across intersectional groups. We propose a single-encoder framework combining dual-level decorrelation with prototype-guided cross-group contrastive learning to reduce demographic dependence while accounting for within-class variation. We further propose Demographic Representation Alignment Reduction (DRAR), a new metric that quantifies the reduction in demographic structure within disease representations. The framework is evaluated on four classification tasks using 34,809 CheXpert test images across eight intersectional groups, defined by age, sex and ethnicity. Compared with empirical risk minimization (ERM), our method reduces the mean equalized-odds gap from 15.41% to 10.86% and the AUC gap from 5.95% to 5.01%. Our method achieves a DRAR of 59.04% relative to ERM, with only a slight decrease in mean AUC. These results demonstrate that representation disentanglement can reduce demographic bias and improve intersectional fairness. Code is available at https://github.com/06Yujie/Fair-Medical-Imaging.

Progress in AI-based retinal image analysis has advanced with foundation models, yet evaluating their reliability remains challenging. Performance reported on a single dataset does not capture how models behave under dataset shift, across clinical definitions, or for different patient subgroups. This limitation is particularly critical in medical imaging analysis, where robustness, calibration, and fairness are essential for safe deployment. We introduce FOCUS (Foundation Ophthalmic Cross-Dataset Understanding under Shift), a cross-dataset benchmark for evaluating retinal fundus models that considers vision-only encoder models (VM), vision-language dual-encoder models (VLM), and multimodal large language models (MLLM). FOCUS harmonizes binary diabetic retinopathy, referable diabetic retinopathy, and glaucomatous optic neuropathy tasks across ten public datasets spanning diverse geographies, acquisition conditions, and label protocols. The benchmark evaluates models through a unified analysis layer that measures ranking performance, calibration, subgroup disparities, and image-quality robustness. We present a large-scale evaluation covering 532 base configurations and 228 MLLM configurations adapted through supervised fine-tuning with low-rank adaptation (LoRA). Results show that no model family consistently dominates across tasks and datasets: general VM encoders achieve the strongest average ranking performance, medical MLLMs are competitive but variable, and dual encoder VLMs benefit substantially from lightweight adaptation. Fine-tuning improves in-domain performance but exhibits heterogeneous transfer to external datasets, particularly in calibration. These findings demonstrate that retinal model evaluation is inherently multidimensional. FOCUS provides a practical framework and public benchmark to assess generalization, reliability, and robustness beyond single-dataset leaderboards

Medical image analysis is often hindered by biased datasets, which can lead to biased models and limited clinical applicability. A promising strategy for mitigating such biases is to augment training data with synthetic images. Counterfactual (CF) generation is one such strategy, though the term is used in two different senses: in some works, CFs are produced through causality-based interventions derived from structural causal models, whereas in others, they are produced by non-causal image edits or conventional conditional generative models, such as altering anatomy or adding pathologies. In this work, we study this distinction and evaluate its practical consequences for medical image augmentation. We compare three conditioning strategies: $\textit{Deterministic}$, which changes selected variables while holding the remaining variables fixed; $\textit{Undirected}$, which updates variables according to learned statistical associations without assigning causal directions; and $\textit{Causal}$, which propagates interventions along a directed causal graph. We analyse how these choices affect the resulting images, and explore when causally grounded methods improve dataset augmentation or bring limited benefit. In particular, we assess downstream performance and fairness, where fairness refers to reduced sensitivity to dataset biases across sensitive subgroups. Our experiments demonstrate that using a causal approach to synthetic training data generation can lead to tangible benefits, with these insights offering valuable guidance to machine learning practitioners for the effective design of data generation protocols.

Fairness audits of medical imaging models commonly report the largest performance difference between demographic subgroups and treat any positive value as evidence of bias. Yet a perfectly fair model also produces a positive difference, which grows as subgroups shrink. Some mitigation methods remove demographic information from models because they assume that it produces the difference. Here we introduce Fair-model Reference And Mechanism Evaluation (FRAME). Its first step compares each reported difference with the difference expected from a perfectly fair model at the same subgroup counts. Its second step tests whether candidate causes of any excess over this fair-model reference change the difference when they are injected into model features. We evaluated 36 encoders on nine datasets in three modalities and audited 89 published differences across six modalities. For 10 frozen encoders and 13 chest radiograph findings, the reference is a median 41% of the race difference and 22% of the age difference. It is exceeded by 40 of 53 published differences in sensitivity or false positive rate and by one of 36 in the area under the receiver operating characteristic curve (AUROC). Adding race information to the features of two encoders does not change the race difference significantly. At matched disease performance, mitigation reduces the race difference by less than its spread across three pretraining seeds (medians 0.005 and 0.012) and the age difference by more (0.008 and 0.006). Image-text pretraining raises the worst-group AUROC for race by a median 0.049 over self-supervised pretraining. Reporting the fair-model reference beside every new and published subgroup difference could direct mitigation to the differences above it.

Skin diseases represent a major global public health burden, yet machine learning tools developed to assist in their diagnosis suffer from two critical limitations: reliance on only one modality for diagnosis and systematic performance disparities across skin tones. While existing approaches address each challenge separately, this work proposes a modality-invariant framework with fair representation (MIFR) for skin disease classification. The architecture pairs clinical photographs with dermoscopic images using ViT-based encoders, projecting each input into a high-dimensional embedding space via modality-specific projection heads. The resulting model is trained with a five-component multi-objective loss including weighted cross-entropy for classification, confusion and skin-type classification losses for fairness, per-modality supervised contrastive loss for class alignment, and a modality-invariance loss for clinical and dermoscopic modality alignment. Experiments on the HIBA+Derm7pt paired dataset and the external PAD-UFES-20 and ISIC 2019 datasets showed that modality-invariant representation learning provides competitive predictive performance compare to relevant baseline models and competitive fairness on the internal dataset. t-SNE visualizations confirmed that clinical and dermoscopic embeddings of the same disease are geometrically aligned, validating the joint objectives.

Per-subgroup fairness audits of medical image classifiers face a sample-size problem: minority subgroups in held-out test sets have so few samples that the resulting confidence intervals on per-subgroup performance are wider than the bias the audit is meant to detect. We argue that a demographically-conditioned synthetic generator can do both: mitigate bias on the training side and detect bias on the evaluation side. Working on COVID-19 chest CT classification with an end-to-end fine-tuned Stable Diffusion 2.1 generator, we make two findings. For bias mitigation (training), a demographically-balanced synthetic cohort is most useful as a pretraining prior, not as joint augmentation: with the same fixed data, sequential pretraining followed by fine-tuning substantially outperforms joint augmentation, and the resulting classifier surpasses the full-real baseline at \sim$$100\times real-data efficiency. For bias detection (evaluation), across five synthetic minority cohorts and five classifier seeds, the synthetic estimator reproduces the subgroup ranking of a well-powered real oracle (Spearman $ρ= 1.00$ on MCC and Recall) and gives the more reliable per-cell estimate where the small real test set runs out of samples. The synthetic cohort is therefore most useful in exactly the cells that fairness audits care about, as both a fix for and a measure of subgroup bias.

Accurate dermatological diagnosis naturally necessitates equitable performance across diverse populations, yet a systematic lack of expertly annotated images, especially for underrepresented skin tones and rare diseases, impedes progress toward measurably fair methods. We introduce cgDDI (Controllable Generation of Diverse Dermatological Imagery), a hybrid framework that (1) synthesizes realistic healthy skin samples without disturbing other input properties, (2) maps single-sample rare lesions onto novel skin-tones and locations non-parametrically, and (3) allows for efficient parametric generation with as few as 10 training samples. The framework supports both human and automated segmentation masking, enabling scalability to datasets without pre-made lesion masks. We grow a 656-image dataset by more than 400x and validate across two datasets: biopsy-confirmed Diverse Dermatology Images (DDI) and expert-verified Fitzpatrick17k (F17k). On the DDI benchmark, we achieve malignancy classification accuracy of 86.4% under synthetic-only training and 90.9% state-of-the-art performance with real data fine-tuning, alongside leading fairness metrics. Cross-dataset experiments show +13.9% accuracy improvements on unseen F17k data despite minimal disease overlap. We openly release 266k+ synthetic images, code, and generative models to further support fairness research at https://github.com/hectorcarrion/ControllableGenDDI.

Deep learning models for medical diagnosis frequently exhibit substantial performance disparities across sensitive subgroups (e.g., race, sex), even when average accuracy is high. While generative data augmentation offers a route to mitigate this, existing strategies are suboptimal; they typically address only one or two dependency channels between sensitive attributes and image features. We formalize the medical image formation process via a structural causal model, revealing that sensitive attributes actually influence image content through four distinct pathways-a structural complexity neglected by prior works. Based on this insight, we introduce CIPHER (Causal Intervention Pathways for Healthcare Equity and Robustness), a framework designed to systematically intervene on all four causal paths. To achieve this, CIPHER utilizes a diffusion backbone equipped with classifier-free guidance and null-text inversion. This technical design enables the faithful reconstruction of patient-specific anatomy while allowing for the precise, editable synthesis of counterfactuals required to break sensitive dependency chains. We tested CIPHER using chest X-ray and dermoscopy benchmarks across both standard and shifted data distributions. By employing a multi-pathway intervention strategy, our model reduced worst-group disparities by an average of 35.8% compared to disease-conditioned synthesis baselines, while also improving total diagnostic accuracy

Artificial intelligence (AI) has achieved remarkable success in medical imaging, but it is widely recognized that these models often perform inconsistently across real-world clinical settings. Such inconsistencies occur when patient demographics and imaging protocols vary, for example, in detecting small tumors, analyzing scans from different contrast phases, or evaluating patients of different ages or sexes. To quantify these inconsistencies, we develop a large-scale, open benchmark of 85,355 CT scans that systematically evaluates 12 tumor-detection AI models across tumor size, location, patient subgroup, and imaging protocol. We leverage large language models (LLMs) to extract and organize subgroup information from clinical data, which makes the analysis both scalable and reproducible. Our benchmark reveals that current state-of-the-art AI models, optimized for average accuracy, perform poorly in rare or underrepresented subgroups, such as young, female African Americans. However, collecting sufficient annotated data for these rare cases is often impractical. The benchmark provides a foundation for building more reliable and robust AI models for tumor detection and highlighting the need for rigorous, subgroup-level evaluation in medical imaging and computer vision. Datasets, code

Medical imaging is central to modern diagnostics, and artificial intelligence (AI) systems are increasingly used to support image-based analysis by improving efficiency, accuracy, and access to care. However, inequities in healthcare access and differential disease prevalence create severe demographic imbalances in clinical image data. Such imbalances are compounded by the fact that diseases can manifest with distinct features across demographic groups, rendering certain phenotypic presentations naturally rare. AI models trained on such imbalanced data risk perpetuating diagnostic bias and widening healthcare disparities. Here we introduce FairGen, a fairness-aware diffusion framework that synthesizes demographically balanced medical images while preserving pathology-relevant visual features. By embedding physician-aligned preferences into the generation process, FairGen improves subgroup coverage during synthesis and downstream classification. Applied to dermatology, radiology, and neuroimaging benchmark tasks, FairGen achieves fairness improvements of 95.9% for skin images, 80.0% for chest radiography, and 35.2% for brain MRI, while maintaining competitive diagnostic accuracy relative to models trained on original clinical data. Clinician-facing expert review and external validation on independent cohorts further support that these gains extend beyond standard fidelity metrics and are not confined to the original in-distribution datasets.

Medical image analysis models can exhibit performance disparities across patient subgroups, threatening clinical safety and fairness. Existing methods typically address this issue by optimizing accuracy and fairness metrics for visible demographic attributes (e.g., sex or age) considered in isolation. This strategy not only overlooks potentially more informative latent stratifications, which may reveal deeper sources of model error and inequity, but also fails to scale when multiple demographic attributes are considered simultaneously due to the resulting sparsity of training data within each subgroup. We deal with these issues by introducing the label-free hidden-cohort fairness (LHCF) training paradigm that instead of maximizing fairness over visible demographic attributes, it optimizes fairness across latent subpopulations discovered from image appearance. By clustering images into K appearance-based cohorts and applying fairness optimization over them, LHCF uncovers underlying sources of model error and avoids the combinatorial sparsity of multi-demographic attributes, reducing disparities across both single and multiple demographic attributes. We demonstrate on our proposed fairness benchmark, HIDFairBench, that LHCF provides state-of-the-art fairness results on single and multiple demographic attributes, despite never using demographic labels for training. Our results position hidden-cohort fairness as a practical, scalable, and robust alternative to demographic-based fairness optimization for trustworthy medical image analysis.

Deep learning models for medical image classification are susceptible to subgroup performance disparities across demographic attributes such as age, gender, and race. We identify a latent representational mechanism underlying these disparities: in transfer-learned models, the dominant penultimate-layer activation channel under positive predictions is co-activated by both disease-positive samples and privileged demographic groups (male, older patients), producing over-diagnosis; conversely, the dominant channel under negative predictions is co-activated by disadvantaged groups (female, younger patients), producing systematic under-diagnosis. To address this, we propose Neuron Incidence Redistribution (NIR), a lightweight regularization method that penalizes the variance of predicted-probability-weighted mean activations across penultimate-layer neurons, requiring no demographic labels at training time. On HAM10000, TPR disparity drops from 10.81% to 0.93% across age groups and from 12.04% to 0.74% across gender, with a marginal AUC improvement of 0.51 points. On Harvard OCT-RNFL, NIR reduces FPR disparity for race (from 15.68% to 10.66%) and age (from 12.69% to 1.80%), demonstrating that distributing latent disease evidence across the full penultimate layer is a principled and effective strategy for improving demographic fairness in medical AI.

Age dependent performance disparities in medical image classification often arise because age acts as a confounder, linking imaging morphology with disease prevalence. In practice, disparities can manifest as overdiagnosis at ages where disease prevalence is higher and underdiagnosis at ages where prevalence is lower, and can worsen under train test shifts in the age distribution. Conventional mitigation approaches that enforce strict age invariance may suppress diagnostically meaningful information encoded in age. We therefore propose a robust framework that mitigates the effects of age-dependent confounding by targeting spurious age linked trends rather than enforcing invariance. Following a warm-up phase, we characterize sample difficulty and model its age-dependent trends in a label-conditioned manner. We decorrelate age from dominant age difficulty trends using robust, Huber weighted affinity weights, attenuating confounding-driven shortcuts while preserving clinically meaningful, nonlinear age information. We further introduce an Age Coverage Score that scales the decorrelation penalty by minibatch age variance to ensure stable optimization under limited age diversity. Across two radiology datasets, our approach reduces age dependent true and false positive disparities with minimal AUC impact and remains robust to increasing train test age distribution shifts.

Diagnostic performance in medical AI varies systematically across demographic groups, yet subgroup AUC can mask clinically important disparities. At a fixed inference-time operating point, some groups may exhibit over-diagnostic behaviour, characterized by elevated true and false positive rates, while others show under-diagnostic patterns with reduced true and false positive rates. These opposing tendencies can cancel in aggregate AUCs while producing meaningful inequities in clinical decision-making. Motivated by the need to assess and mitigate such disparities at the operating point and across multiple demographic attributes simultaneously, we propose a worst-group equalized-odds margin regularizer. The proposed regularizer explicitly targets subgroup-level deviations on both the true positive and false positive sides at inference. At each update, the method identifies subgroups defined by explicit demographic attributes (e.g., age, sex, and race) that exhibit the most extreme margin deviations and applies a unified penalty, enabling fairness optimization across multiple demographic axes without requiring explicit intersectional constraints. Across two medical imaging datasets in realistic multi-label settings, our method consistently reduces disparities in Equalized Odds and Equalized Opportunity with minimal impact on AUC, preserving diagnostic performance while improving fairness.

Machine learning models for medical image analysis often exhibit subgroup-dependent performance, which impacts how decisions should be allocated between automated systems and human experts under limited resources. Prior work on AI fairness and human-AI cooperation, including learning to defer (L2D) and learning to complement (L2C), typically addresses these problems in isolation. We propose People-Centred Medical Image Analysis (PecMan), a framework for fairness-aware human-AI co-operative classification that jointly models subgroup-dependent reliability, decision allocation, and collaborative prediction. PecMan combines subgroup-specialised predictors with a gating and consolidation mechanism that dynamically assigns cases to automated models, human experts, or their combination, without requiring sensitive attributes at test time. We also introduce the FairHAI benchmark for evaluating trade-offs between predictive accuracy, subgroup equity, and human involvement. In addition, we provide a theoretical analysis of multi-agent gating via selection regret and characterise fairness-coverage trade-offs under input-dependent allocation. Experiments across multiple medical imaging datasets demonstrate that PecMan achieves consistently improved trade-offs compared to methods that address fairness or human-AI cooperation separately.

Automated diagnosis from chest CT has improved considerably with deep learning, but models trained on skewed datasets tend to perform unevenly across patient demographics. However, the situation is worse than simple demographic bias. In clinical data, class imbalance and group underrepresentation often coincide, creating compound failure modes that neither standard rebalancing nor fairness corrections can fix alone. We introduce a two-level objective that targets both axes of this problem. Logit-adjusted cross-entropy loss operates at the sample level, shifting decision margins by class frequency with provable consistency guarantees. Conditional Value at Risk aggregation operates at the group level, directing optimization pressure toward whichever demographic group currently has the higher loss. We evaluate on the Fair Disease Diagnosis benchmark using a 3D ResNet-18 pretrained on Kinetics-400, classifying CT volumes into Adenocarcinoma, Squamous Cell Carcinoma, COVID-19, and Normal groups with patient sex annotations. The training set illustrates the compound problem concretely: squamous cell carcinoma has 84 samples total, 5 of them female. The combined loss reaches a gender-averaged macro F1 of 0.8403 with a fairness gap of 0.0239, a 13.3% improvement in score and 78% reduction in demographic disparity over the baseline. Ablations show that each component alone falls short. The code is publicly available at https://github.com/Purdue-M2/Fair-Disease-Diagnosis.

Skin cancer, particularly melanoma, remains a major cause of morbidity and mortality, making early detection critical. AI-driven dermatology systems often rely on skin lesion segmentation as a preprocessing step to delineate the lesion from surrounding skin and support downstream analysis. While fairness concerns regarding skin tone have been widely studied for lesion classification, the influence of skin tone on the segmentation stage remains under-quantified and is frequently assessed using coarse, discrete skin tone categories. In this work, we evaluate three strong segmentation architectures (UNet, DeepLabV3 with a ResNet50 backbone, and DINOv2) on two public dermoscopic datasets (HAM10000 and ISIC2017) and introduce a continuous pigment or contrast analysis that treats pixel-wise ITA values as distributions. Using Wasserstein distances between within-image distributions for skin-only, lesion-only, and whole-image regions, we quantify lesion skin contrast and relate it to segmentation performance across multiple metrics. Within the range represented in these datasets, global skin tone metrics (Fitzpatrick grouping or mean ITA) show weak association with segmentation quality. In contrast, low lesion-skin contrast is consistently associated with larger segmentation errors in models, indicating that boundary ambiguity and low contrast are key drivers of failure. These findings suggest that fairness improvements in dermoscopic segmentation should prioritize robust handling of low-contrast lesions, and the distribution-based pigment measures provide a more informative audit signal than discrete skin-tone categories.

Automated diagnosis from chest computed tomography (CT) scans faces two persistent challenges in clinical deployment: distribution shift across acquisition sites and performance disparity across demographic subgroups. We address both simultaneously across two complementary tasks: binary COVID-19 classification from multi-site CT volumes (Task 1) and four-class lung pathology recognition with gender-based fairness constraints (Task 2). Our framework combines a lightweight MobileViT-XXS slice encoder with a two-layer SliceTransformer aggregator for volumetric reasoning, and trains with a KL-regularised Group Distributionally Robust Optimisation (Group DRO) objective that adaptively upweights underperforming acquisition centres and demographic subgroups. Unlike standard Group DRO, the KL penalty prevents group weight collapse, providing a stable balance between worst-case protection and average performance. For Task 2, we define groups at the granularity of gender class, directly targeting severely underrepresented combinations such as female Squamous cell carcinoma. On Task 1, our best configuration achieves a challenge F1 of 0.835, surpassing the best published challenge entry by +5.9. On Task 2, Group DRO with α = 0.5 achieves a mean per-gender macro F1 of 0.815, outperforming the best challenge entry by +11.1 pp and improving Female Squamous F1 by +17.4 over the Focal Loss baseline.